Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-22

Clinical Trial Update: Amitriptyline to Prevent Headache After Traumatic Brain Injury [Phase 2]

View source ↗

Summary

A Phase 2 trial tested amitriptyline for preventing post-traumatic headaches after traumatic brain injury; the study completed and results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • amitriptyline (amitriptyline)

Snippet

Sponsor: University of Washington | Conditions: Brain Injuries, Post-Traumatic Headache | Phase 2 | Status: COMPLETED | Results posted: 2017-12-22